Omicron thoughts from dark, Christmas London. TL;DR - Europe+World is facing the Omicron storm and it looks increasingly bad; and, obviously, the virus doesn't care about Christmas. Despite some serious response in the UK, this virus is replicating fast; more action likely needed
Context: I am an expert in human genetics and computational biology. I know experts in infectious epidemiology, viral genomics, immunology and clinical trials. I have some COIs: I am consultant and shareholder of ONT and was on the Ox/Az trial.
Reminder: SARS-CoV-2 is a recently jumped coronavirus into humans which causes a very nasty disease, COVID, in a subset of people. It has rushed across the world over 2 years, combatted by lockdowns and more recently vaccines, but causing death and disease in many places.
The SARS-CoV-2 virus has evolved to create it's first "antigen drift" variant - Omircon - a common way coronaviruses continue to circulate in populations by having enough changes in their spike protein to look different.
Omicron was first characterised in South Africa, which remains furthest along the Omicron wave so far. It would have been awful if many people died or were in hospital in SA, but, thankfully it looks like the wave in SA is less damaging than the previous Delta wave.
But this experience need not match to Europe - Europe's population is older and there has been far far less prior infection (due to lockdowns and vaccines). This means one can't map one to one the experience in SA to Europe or other places (each with it's own mix).
The UK and Denmark, presumably along with the rest of Europe, was seeded with Omicron some 3 weeks ago (the time scale is *so short*) and probably due to both countries relying on vaccination, strong vs Delta, Omicron established quickly in both locations.
In both places Omicron's doubling rate has been in the order of 2 to 3 days. This means 4-8 fold a week - and *25-128* fold per 2 weeks. The graphs are bonkers and scary. All SARS-CoV-2 infection graphs will "hockey stick" pretty much everywhere I suspect over this month.
At this rate lags of days (or weeks in some countries for some data assets) between for swabbing, testing, testing/sequencing for omicron, data flow and analysis are meaningful. For example, it's simply not clear to me what the level of Omicron is in France.
Reassuringly and mainly due to prompt data flows from the UK we can be pretty certain that 3 doses (3x mRNA or 2x Adeno, 1x mRNA) greatly reduces symptoms and most likely really suppresses severe disease. ie, Boosters work. Boost-baby-Boost.
Infection is one thing, but what decision makers want to know about is hospitalisations; again, the time from sense to decide to respond to change infection patterns is probably too short to be sure; one has to make decisions on far lighter data than one would wish.
It's worth pointing out the obvious. The virus isn't sentient (duh!); it doesn't know about Christmas or any winter events, and it genuinely does not care. Throw out your human schedule, view the schedule from the viruses' perspective to understand the risks.
"For the forthcoming wave to remain around or below 1,000 to 2,000 total hospital admissions per day without intervention, low immune escape and very high protection from boosters are required to be consistent with the estimated omicron growth rate >>
[reasonable modelling assumptions] for omicron growth advantage, generally have a minimum of 5,000 hospital admissions per day at the peak with many scenarios significantly worse during the first few months of 2022"
"To prevent a wave of hospitalisations similar to those seen in Spring 2020 and January 2021, without the need to slow growth with interventions, the severity of omicron would need to be between 10% and 30% that of delta."
This is a small parameter space for the UK to be "ok" (for some definition of ok) and importantly by the time we have good evidence of Omicron severity it is likely to be too late to react. Crunching the numbers from SA is useful but not the UK/European scenario.
Plus really large infection has incredible complications on healthcare (eg, rostas, dealing with healthcare staff infected) even if in theory ok and de facto lockdown like situations for hospitality (staff reasons, customer fear).
Other high elderly vaxed countries with a prompt booster campaign - Denmark, Portgual, Ireland for example - are likely to be a similar position to the UK. Lower vaxed, in particular in the old ages, such as likely in some parts of Germany (eg, Saxony) have still thinner margins
Eastern Europe, with higher previous infection but less vaccination is harder to call - one would need to do modelling of this and again many parameters one would just have to guess at now.
I can't see western Europe getting through this without some level of lockdowns, perhaps circuit breaker ones to ease off healthcare pressure, let booster campaigns complete, leaving some NPIs to see out Omicron wave.
For countries with significant numbers of vaccine hestitant people, it is going to be far more complex. A mixture of carrots and sticks likely needed (personally I think there's been too much focus on sticks - mandates, fines etc; Slovakia's vaccine voucher inverts this).
Looking beyond Omicron - hard to do at the moment - we are going to have to regularly deal with antigenic drift of this virus (as we do, unknowingly, for the other 4 endemic coronavirus). This level of disrupution is ... not sustainable, so we will need everything to work better
Rounds of infection will no doubt help; I still think we need to have some level of focus on the (inappropriate) host response for COVID, which is a CFS like viral-triggered auto-immune disease; ie, tackling the disease not the infection. A long road for new drugs though.
In the meantime we've got to get through the Omicron wave. Remember to be kind to yourself, your family, friends and strangers - nearby and worldwide. This is getting humans through this thing, and we're going to have to be resilent and caring to all.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
One consistent thing in this pandemic is for a given virus biology (parameters of infection, immune escape, disease severity) the growth or reduction fits models / understanding well
(A short diversion here between forecast/now cast models - accurately predicting the next handful of days - and scenario models - helping decision makers plan given uncertain parameters and choices for intervention-
Forecast models absolutely should be benchmarked to outturn. Scenario models for the discovered parameters and interventions benchmarked by shape and size but less so timing)
COVID thoughts from cold, Christmas London. TL;DR The Omicron storm clouds are glowering above Europe, but its unclear whether this will just be rain and hail of COVID or rain, hail, tornados and hurricanes of infection and subsequent hospitalisation of COVID.
Context: I am an expert in human genetics and computational biology. I know experts in infectious epidemiology, viral genomics, immunology, public health and clinical trials. I have COIs - I am consultant and shareholder to Oxford Nanopore and was on the Ox/Az vaccine trial.
Reminder: COVID is horrible disease triggered by the infection of SARS-CoV-2 in a subset of people. A combination of reducing contacts (early), reducing travel (some countries) and vaccination brought SARS-CoV-2 towards a somewhat endemic trajectory over 2020 and 2021. However >>
This is in my crude list of effectiveness; one is missing which is the "don't meet people" (its simple. not long term.) and this has to be kept on the table as a possibility. To step through them.
My view of COVID from crisp, cold Helsinki (back to London - with PCR test - on Tue). TL;DR Omicron has thrown us back to a place of uncertainity; we have far more potent tools+understanding now but the trajectory will be mainly determined by the biological properties of Omicron
Context: I am expert in human genetics and computational biology. I know experts in viral genomics, infectious epidemiology, clinical trials and immunology. I have some conflicts of interest; I am paid consultant and shareholder of Oxford Nanopore and was on the Ox/Az trial.
Key background: COVID is a virus-triggered disease, with hallmarks of auto-immune disease, triggered by a novel, highly infectious Coronavirus, SARS-CoV-2. In naive populations many people would get this disease, many of those dieing, and healthcare would be overwhelmed
A great collaboration on direct RNA sequencing of SARS-CoV-2 transcripts using nanopore sequencing from Camilla Ugolini (Italian Institute of Technology) and colleagues, lead by Tomasso Leonardi (IIT) and Dave Matthews (Bristol) - I am a co-author. biorxiv.org/content/10.110…
(note; I and some other authors, eg, @AkesonUCSC have conflict of interests to declare as I am long standing consultant to Oxford Nanopore and shareholder).
Camilla looked at SARS-CoV-2 transcripts using a neat new protocol that both captures capped (full length) RNAs and can sequence through them, NRCseq, developed by @ettwiller (also a co-author). This means Camilla can distinguish full length from degraded transcripts.
A brief explainer thread on B.1.1.529, the latest SARS-CoV-2 variant which is throwing up concern after an excellent live streamed press conference from South Africa. TL;DR this variant both has many mutations but most importantly looks like it outcompeting delta in South Africa
Context: I am a expert in human genetics and computational biology; I know experts in viral genomics, infectious epidemiology, clinical trials and immunology. I have some conflicts of interest: I am longstanding consultant to Oxford Nanopore and was on the Ox/Az clincal trail
Background. The SARS-CoV-2 virus is made from RNA (its instruction set) wrapped in proteins. The RNA+proteins of the virus hijack our cells to make more of its RNA and proteins into a virus. This hijacking (infection) causes a response from our immune system.